Dette gælder især i begyndelsen af INCRELEX- behandlingen og indtil der er fastlagt en INCRELEX- dosis, hvor der ikke forekommer betydelige behandlingsrelaterede bivirkninger
Patients should avoid engaging in any high-risk activities (e.g., driving, etc.) within 2-3 hours after dosing, particularly at the initiation of INCRELEX treatment, until a dose of INCRELEX has been established without occurrence of significant treatment-related adverse events.